Stéphanie Proust

558 total citations
11 papers, 131 citations indexed

About

Stéphanie Proust is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stéphanie Proust has authored 11 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stéphanie Proust's work include Sarcoma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (3 papers) and Hepatitis C virus research (3 papers). Stéphanie Proust is often cited by papers focused on Sarcoma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (3 papers) and Hepatitis C virus research (3 papers). Stéphanie Proust collaborates with scholars based in France, United States and Ireland. Stéphanie Proust's co-authors include Noufϊssa Oudrhiri, Anne Sophie Defachelles, Anne‐Marie Roque‐Afonso, Ali G. Turhan, Anne Ebel, Emilie Gobbo, Annelise Bennaceur‐Griscelli, Aurélie Magniez, Lina Mouna and Olivier Féraud and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and European Journal of Cancer.

In The Last Decade

Stéphanie Proust

10 papers receiving 130 citations

Peers

Stéphanie Proust
Iván Murrieta-Álvarez Mexico
Simone Cosima Boedecker-Lips Germany
Ibrahim Al Abdulkareem Saudi Arabia
Maged H. Hussein Saudi Arabia
Yongrong Lai China
Ana Purroy Spain
Marcelo Luiz Balancin Brazil
Biljana Brezina United Kingdom
Norihito Omote Japan
Iván Murrieta-Álvarez Mexico
Stéphanie Proust
Citations per year, relative to Stéphanie Proust Stéphanie Proust (= 1×) peers Iván Murrieta-Álvarez

Countries citing papers authored by Stéphanie Proust

Since Specialization
Citations

This map shows the geographic impact of Stéphanie Proust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Proust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Proust more than expected).

Fields of papers citing papers by Stéphanie Proust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Proust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Proust. The network helps show where Stéphanie Proust may publish in the future.

Co-authorship network of co-authors of Stéphanie Proust

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Proust. A scholar is included among the top collaborators of Stéphanie Proust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Proust. Stéphanie Proust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Borovkov, A. I., Daniel Orbach, Liana Carausu, et al.. (2025). Desmoid‐Type Fibromatosis Tumors in Children After First‐Line Failure: Clinical Aspects and Approaches for Subsequent Therapeutic Lines. Pediatric Blood & Cancer. 72(9). e31866–e31866. 1 indexed citations
2.
Pasqualini, Claudia, Stéphanie Proust, Gudrun Schleiermacher, et al.. (2025). Chemo‐Immunotherapy Rescue for High‐Risk Neuroblastoma Patients With Progressive Disease Before High‐Dose Chemotherapy: Real‐World Data From the SACHA‐France Study. Pediatric Blood & Cancer. 72(12). e32080–e32080.
3.
Bogart, Emilie, Daniel Orbach, Marie‐Cécile Le Deley, et al.. (2024). Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee. Cancer Medicine. 13(23). e70420–e70420. 1 indexed citations
4.
Mouna, Lina, Coralie Pallier, Stéphanie Proust, & Anne‐Marie Roque‐Afonso. (2022). Comparison of serum and plasma viral load measurements in human immunodeficiency virus type 1 infection. SHILAP Revista de lepidopterología. 3(1). 100127–100127. 2 indexed citations
5.
Minard‐Colin, Véronique, Nadège Corradini, Guy Leverger, et al.. (2021). Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tissue sarcoma Study Group recommendations. European Journal of Cancer. 161. 64–78. 11 indexed citations
6.
Mouna, Lina, et al.. (2020). Comparison of the Abbott Alinity m and m2000 assays for the quantification of HIV-1, HCV and HBV in clinical samples. Journal of Clinical Virology. 126. 104331–104331. 10 indexed citations
7.
Karanian, Marie, Gaëlle Pierron, Daniel Orbach, et al.. (2020). Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee. Cancer Medicine. 9(8). 2698–2709. 25 indexed citations
8.
Ortiz, Michael V., Ulrike Gerdemann, Dahlia Henry, et al.. (2020). Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring RET Gene Alterations. JCO Precision Oncology. 4(4). 341–347. 27 indexed citations
9.
Kolesnikov-Gauthier, H., A. Oudoux, Gudrun Schleiermacher, et al.. (2018). Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma: The French Experience. Journal of Pediatric Hematology/Oncology. 40(6). 426–432. 11 indexed citations
10.
11.
Magniez, Aurélie, Noufϊssa Oudrhiri, Olivier Féraud, et al.. (2014). Morphological Analysis of Human Induced Pluripotent Stem Cells During Induced Differentiation and Reverse Programming. BioResearch open access. 3(5). 206–216. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iván Murrieta-Álvarez Breakdown of academic impact, for papers by Simone Cosima Boedecker-Lips Breakdown of academic impact, for papers by Ibrahim Al Abdulkareem Breakdown of academic impact, for papers by Maged H. Hussein Breakdown of academic impact, for papers by Yongrong Lai Breakdown of academic impact, for papers by Ana Purroy Breakdown of academic impact, for papers by Marcelo Luiz Balancin Breakdown of academic impact, for papers by Biljana Brezina Breakdown of academic impact, for papers by Norihito Omote
Rankless by CCL
2026